RU2006127945A - METHOD FOR TREATING PATIENTS WITH IMPAIRED MEMORY FUNCTION - Google Patents

METHOD FOR TREATING PATIENTS WITH IMPAIRED MEMORY FUNCTION Download PDF

Info

Publication number
RU2006127945A
RU2006127945A RU2006127945/14A RU2006127945A RU2006127945A RU 2006127945 A RU2006127945 A RU 2006127945A RU 2006127945/14 A RU2006127945/14 A RU 2006127945/14A RU 2006127945 A RU2006127945 A RU 2006127945A RU 2006127945 A RU2006127945 A RU 2006127945A
Authority
RU
Russia
Prior art keywords
memory function
treating patients
impaired memory
agent
impaired
Prior art date
Application number
RU2006127945/14A
Other languages
Russian (ru)
Other versions
RU2335291C2 (en
Inventor
Сергей В чеславович Ширинкин (RU)
Сергей Вячеславович Ширинкин
Original Assignee
Сергей В чеславович Ширинкин (RU)
Сергей Вячеславович Ширинкин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сергей В чеславович Ширинкин (RU), Сергей Вячеславович Ширинкин filed Critical Сергей В чеславович Ширинкин (RU)
Priority to RU2006127945/14A priority Critical patent/RU2335291C2/en
Publication of RU2006127945A publication Critical patent/RU2006127945A/en
Application granted granted Critical
Publication of RU2335291C2 publication Critical patent/RU2335291C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Alcoholic Beverages (AREA)

Claims (1)

Способ лечения больных с нарушением функции памяти, включающий введение средства, обладающего ноотропной активностью, отличающийся тем, что в качестве средства, обладающего ноотропной активностью, используют водно-минеральный раствор природных фуллеренов концентрацией 0,25-0,5 мг/л, при этом раствор применяют в виде питья в течение 15 суток.A method of treating patients with impaired memory function, comprising administering an agent having nootropic activity, characterized in that an aqueous-mineral solution of natural fullerenes with a concentration of 0.25-0.5 mg / l is used as an agent having nootropic activity, the solution being used as a drink for 15 days.
RU2006127945/14A 2006-07-28 2006-07-28 Method of treatment of patients with memory dysfunction RU2335291C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006127945/14A RU2335291C2 (en) 2006-07-28 2006-07-28 Method of treatment of patients with memory dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006127945/14A RU2335291C2 (en) 2006-07-28 2006-07-28 Method of treatment of patients with memory dysfunction

Publications (2)

Publication Number Publication Date
RU2006127945A true RU2006127945A (en) 2008-02-10
RU2335291C2 RU2335291C2 (en) 2008-10-10

Family

ID=39265849

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006127945/14A RU2335291C2 (en) 2006-07-28 2006-07-28 Method of treatment of patients with memory dysfunction

Country Status (1)

Country Link
RU (1) RU2335291C2 (en)

Also Published As

Publication number Publication date
RU2335291C2 (en) 2008-10-10

Similar Documents

Publication Publication Date Title
MX338338B (en) Compositions and methods useful for treatment of respiratory illness.
EA201070121A1 (en) DOSAGE FORM CONTAINING A SLIP PROTEIN GLP-1-FC
WO2006119958A3 (en) Use of flibanserin in the treatment of chronic pain
MX295630B (en) Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients.
EA200700407A1 (en) HINAZOLIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOCYTHEMIA
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
EA200802412A1 (en) THERAPEUTIC COMBINATIONS FOR SUPPORTING MEDICAL CONDITIONS
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
BRPI0722054A2 (en) COMPOSITION, KIT, AND METHODS TO REDUCE A SIDE TREATMENT EFFECT WITH A CALCINEURIN INHIBITOR, TO INCREASE A THERAPEUTIC EFFECT OF A CALCINEURIN INHIBITOR AND TO CHANGE THE CONCENTRATION OF TACROLIMUS OR ANALYLOGAL ANALOGUE
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
RS54140B1 (en) Use of 24-norudca
GB0620255D0 (en) Antibody and uses thereof
TW200738255A (en) Methods of regulating renalase (Monoamine Oxidase C)
HK1116760A1 (en) Use of an organic reducing agent for removing chloramine, chlorine and other active chlorine compounds from aquaculture water for water organisms
EP1629852A3 (en) Topical anaesthesia formulation for bodily cavities
EA201070194A1 (en) STABLE LIQUID PHARMACEUTICAL COMPOSITION BASED ON TRAZODONE
IL185807A0 (en) Use of amino-substituted benzimidazoles
RU2006127945A (en) METHOD FOR TREATING PATIENTS WITH IMPAIRED MEMORY FUNCTION
MX2009006670A (en) Pharmaceutical composition using aliskiren and avosentan.
WO2007021933A3 (en) Methods and compositions for use in treating vascular diseases and conditions
RS52237B (en) Carnitine-containing peritoneal dialysis solution having improved biocompatibility
RU2005111089A (en) METHOD FOR TREATMENT OF PUNCHED RESIDUAL CAVITIES OF THE LIVER AFTER ECHINOCOCCECTOMY
CY1112144T1 (en) UNION USEFUL FOR THE PREVENTION AND TREATMENT OF LOW VOLUME COVERAGE IN PATIENTS WITH BLOOD CLEANING
RU2004116284A (en) METHOD FOR BONE CAVITY TREATMENT AFTER NECRSECVESTRECTOMY

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20090729